Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 (OTLKW)

OTLKW was delisted on the 16th of February, 2022.

• Market cap: $6.73M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Employees: 9